131I treatment for thyroid cancer in patients under haemodialysis (HD)

被引：0
|
作者：
Magri, G. C. [1 ]
De Agostini, A.
Movili, E. [2 ,3 ]
Gabanelli, S. V. [4 ]
Merli, G. [4 ]
Rodella, C. A.
Caobelli, F. [4 ]
Jeannin, G. [2 ,3 ]
Zubani, R. [2 ,3 ]
Giubbini, R. [4 ]
机构：
[1] Spedali Civil Brescia, Dpt Nucl Med, I-25125 Brescia, Italy
[2] Univ Brescia, Div Nephrol, I-25121 Brescia, Italy
[3] Univ Brescia, Chair Nephrol, I-25121 Brescia, Italy
[4] Univ Brescia, Chair Nucl Med, I-25121 Brescia, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [31] Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
    Doi, SAR
    Woodhouse, NJY
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 765 - 773
  • [32] 131I effective half-life and dosimetry in thyroid cancer patients
    Remy, Herve
    Borget, Isabelle
    Lebulieux, Sophie
    Guilabert, Nadine
    Lavielle, Frederic
    Garsi, Jerome
    Bournaud, Claire
    Gupta, Severine
    Schlumberger, Martin
    Ricard, Marcel
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) : 1445 - 1450
  • [33] Effect of 131I treatment on parathyroid function in patients with differentiated thyroid carcinoma
    Xiao, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S587
  • [34] Hierarchy of treatment variables affecting outcome of 131I therapy in thyroid cancer patients with lung metastases
    Kozak, OV
    Sukach, GG
    Korchinskaya, OI
    Trembach, AM
    Turicina, VL
    Voit, NU
    EXPERIMENTAL ONCOLOGY, 2005, 27 (02) : 150 - 155
  • [35] Practical dosimetry of 131I in patients with thyroid carcinoma
    Sisson, JC
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) : 101 - 105
  • [36] Influence of the 131I activity on the probability of remnants ablation in thyroid cancer patients
    Kozak, OV
    EXPERIMENTAL ONCOLOGY, 2001, 23 (04): : 291 - 293
  • [37] MEASUREMENT OF RADIATION EXPOSURE IN RELATIVES OF THYROID CANCER PATIENTS TREATED WITH 131I
    Ramirez-Garzon, Y. T.
    Avila, O.
    Medina, L. A.
    Gamboa-deBuen, I.
    Rodriguez-Laguna, A.
    Buenfil, A. E.
    Ruiz-Trejo, C.
    Estrada, E.
    Brandan, M. E.
    HEALTH PHYSICS, 2014, 107 (05): : 410 - 416
  • [38] Radiation protection issues of treating hyperthyroidism with 131I in patients on haemodialysis
    Homer, L
    Smith, AH
    NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (03) : 261 - 264
  • [39] Effectiveness of 131I iodine under rhTSH stimulation in treatment of advanced, non-operable thyroid cancer
    Ledwon, A.
    Paliczka-Cieslik, E.
    Kropinska, A.
    Blewaska, A.
    Olczyk, T.
    Kluczewska-Galka, A.
    Handkiewicz-Junak, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S560 - S560
  • [40] The clinical usefulness of 131I scans on tenth day after 131I therapy in patients with well-differentiated thyroid cancer: comparison with third day 131I scans
    Lee, J.
    Lee, S.
    Koh, G.
    Lee, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S345 - S346
12345